FDA Approved: FELBAMATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for felbamate from Amneal Pharmaceuticals of New York LLC, expanding the existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• FELBAMATE (felbamate)

Snippet

SUPPL AP for FELBAMATE (FELBAMATE)